Related Experiment Video
Updated: Jul 25, 2026
05:18
Derivation of Leptomeninges Explant Cultures from Postmortem Human Brain Donors
Published on: January 21, 2017
Dementia with Lewy bodies: a pure case
J M Gurd1, L Herzberg, C Joachim
1University Department of Clinical Neurology, Oxford, UK. gurd@ermine.ox.ac.uk
Brain and Cognition
|December 6, 2000
Summary
This case study details a pure dementia with Lewy bodies (DLB) confirmed by autopsy. Early diagnosis is crucial for managing DLB risks and improving patient care.
Area of Science:
- Neurology
- Neuroscience
- Pathology
Background:
- Dementia with Lewy bodies (DLB) presents diagnostic challenges, necessitating clear case studies for accurate identification.
- Distinguishing DLB from other neurodegenerative diseases like Alzheimer's disease is critical for appropriate patient management and treatment.
Observation:
- A patient exhibited specific verbal fluency deficits with mild language impairment, preserved recognition memory, and impaired paragraph recall.
- Neuroimaging revealed progressive medial temporal lobe atrophy, while autopsy confirmed Lewy bodies and degeneration in key brain areas, excluding Alzheimer's pathology.
Findings:
- The autopsy-confirmed case demonstrated a "pure" form of dementia with Lewy bodies, characterized by specific cognitive deficits and neuropathological findings.
- Neuropathological examination identified Lewy bodies and degeneration in the substantia nigra, nucleus basalis of Meynert, and locus ceruleus.
Implications:
- Early and accurate neuropsychological diagnosis of DLB is essential due to the severe risks associated with neuroleptic medication.
- This case underscores the importance of detailed neuropathological examination in confirming DLB diagnoses and differentiating it from other dementias.
Related Concept Videos
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
01:30Dementia
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual.
The progression of dementia is generally gradual.
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
01:24Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
01:22Dementia l: Introduction
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...